Gastroenterology
Volume 136, Issue 3 , Pages 872-882.e3 , March 2009

Tissue-Specific Amino Acid Transporter Partners ACE2 and Collectrin Differentially Interact With Hartnup Mutations

  • Simone M.R. Camargo

      Affiliations

    • Institute of Physiology and Zürich Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland
    • ,
  • Dustin Singer

      Affiliations

    • Institute of Physiology and Zürich Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland
    • ,
  • Victoria Makrides

      Affiliations

    • Institute of Physiology and Zürich Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland
    • ,
  • Katja Huggel

      Affiliations

    • Institute of Physiology and Zürich Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland
    • ,
  • Klaas M. Pos

      Affiliations

    • Institute of Physiology and Zürich Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland
    • ,
  • Carsten A. Wagner

      Affiliations

    • Institute of Physiology and Zürich Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland
    • ,
  • Keiji Kuba

      Affiliations

    • IMBA, Institute for Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria
    • ,
  • Ursula Danilczyk

      Affiliations

    • IMBA, Institute for Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria
    • ,
  • Flemming Skovby

      Affiliations

    • Department of Clinical Genetics, Copenhagen University Hospital, Copenhagen, Denmark
    • ,
  • Robert Kleta

      Affiliations

    • University College London, London, England
    • Corresponding Author InformationReprint requests Address requests for reprints to: François Verrey, MD, Institute of Physiology, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland. Robert Kleta, MD, Centre for Nephrology, University College London, Rowland Hill Street, London NW3 2PF, England. Josef M. Penninger, MD, IMBA, Institute of Molecular Biotechnology, Dr. Bohr-Gasse 3, A-1030 Vienna, Austria
    • ,
  • Josef M. Penninger

      Affiliations

    • IMBA, Institute for Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria
    • Corresponding Author InformationReprint requests Address requests for reprints to: François Verrey, MD, Institute of Physiology, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland. Robert Kleta, MD, Centre for Nephrology, University College London, Rowland Hill Street, London NW3 2PF, England. Josef M. Penninger, MD, IMBA, Institute of Molecular Biotechnology, Dr. Bohr-Gasse 3, A-1030 Vienna, Austria
    • ,
  • François Verrey

      Affiliations

    • Institute of Physiology and Zürich Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland
    • Corresponding Author InformationReprint requests Address requests for reprints to: François Verrey, MD, Institute of Physiology, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland. Robert Kleta, MD, Centre for Nephrology, University College London, Rowland Hill Street, London NW3 2PF, England. Josef M. Penninger, MD, IMBA, Institute of Molecular Biotechnology, Dr. Bohr-Gasse 3, A-1030 Vienna, Austria

Received 23 May 2008 ,Accepted 23 October 2008.

References 

  1. Kleta R, Romeo E, Ristic Z, et al. Mutations in SLC6A19, encoding B0AT1, cause Hartnup disorder. Nat Genet. 2004;36:999–1002
  2. Seow HF, Broer S, Broer A, et al. Hartnup disorder is caused by mutations in the gene encoding the neutral amino acid transporter SLC6A19. Nat Genet. 2004;36:1003–1007
  3. Danilczyk U, Sarao R, Remy C, et al. Essential role for collectrin in renal amino acid transport. Nature. 2006;444:1088–1091
  4. Malakauskas SM, Quan H, Fields TA, et al. Aminoaciduria and altered renal expression of luminal amino acid transporters in mice lacking novel gene collectrin. Am J Physiol Renal Physiol. 2007;292:F533–F544
  5. Crackower MA, Sarao R, Oudit GY, et al. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature. 2002;417:822–828
  6. Li W, Moore MJ, Vasilieva N, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426:450–454
  7. Kuba K, Imai Y, Rao S, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med. 2005;11:875–879
  8. Hamming I, Timens W, Bulthuis ML, et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus (A first step in understanding SARS pathogenesis). J Pathol. 2004;203:631–637
  9. To KF, Lo AW. Exploring the pathogenesis of severe acute respiratory syndrome (SARS): the tissue distribution of the coronavirus (SARS-CoV) and its putative receptor, angiotensin-converting enzyme 2 (ACE2). J Pathol. 2004;203:740–743
  10. Paunescu TG, Da Silva N, Marshansky V, et al. Expression of the 56-kDa B2 subunit isoform of the vacuolar H(+)-ATPase in proton-secreting cells of the kidney and epididymis. Am J Physiol Cell Physiol. 2004;287:C149–C162
  11. Romeo E, Dave MH, Bacic D, et al. Luminal kidney and intestine SLC6 amino acid transporters of B0AT-cluster and their tissue distribution in Mus musculus. Am J Physiol Renal Physiol. 2006;290:F376–F383
  12. Biber J, Stieger B, Haase W, et al. A high yield preparation for rat kidney brush border membranes (Different behaviour of lysosomal markers). Biochim Biophys Acta. 1981;647:169–176
  13. Inigo C, Barber A, Lostao MP. Na+ and pH dependence of proline and beta-alanine absorption in rat small intestine. Acta Physiol (Oxf). 2006;186:271–278
  14. Guy JL, Jackson RM, Jensen HA, et al. Identification of critical active-site residues in angiotensin-converting enzyme-2 (ACE2) by site-directed mutagenesis. FEBS J. 2005;272:3512–3520
  15. Zhang Y. I-TASSER server for protein 3D structure prediction. BMC Bioinformatics. 2008;9:40
  16. Yamashita A, Singh SK, Kawate T, et al. Crystal structure of a bacterial homologue of Na+/Cl−-dependent neurotransmitter transporters. Nature. 2005;437:215–223
  17. Camargo SM, Makrides V, Virkki LV, et al. Steady-state kinetic characterization of the mouse B(0)AT1 sodium-dependent neutral amino acid transporter. Pflugers Arch. 2005;451:338–348
  18. Ehnes C, Forster IC, Kohler K, et al. Structure-function relations of the first and fourth predicted extracellular linkers of the type IIa Na+/Pi cotransporter: I (Cysteine scanning mutagenesis). J Gen Physiol. 2004;124:475–488
  19. Franca R, Veljkovic E, Walter S, et al. Heterodimeric amino acid transporter glycoprotein domains determining functional subunit association. Biochem J. 2005;388:435–443
  20. Donoghue M, Hsieh F, Baronas E, et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res. 2000;87:E1–E9
  21. Tipnis SR, Hooper NM, Hyde R, et al. A human homolog of angiotensin-converting enzyme (Cloning and functional expression as a captopril-insensitive carboxypeptidase). J Biol Chem. 2000;275:33238–33243
  22. Zhang H, Wada J, Hida K, et al. Collectrin, a collecting duct-specific transmembrane glycoprotein, is a novel homolog of ACE2 and is developmentally regulated in embryonic kidneys. J Biol Chem. 2001;276:17132–17139
  23. Kowalczuk S, Broer A, Tietze N, et al. A protein complex in the brush-border membrane explains a Hartnup disorder allele. FASEB J. 2008;22:2880–2887
  24. Sato Y, Zhang YW, Androutsellis-Theotokis A, et al. Analysis of transmembrane domain 2 of rat serotonin transporter by cysteine scanning mutagenesis. J Biol Chem. 2004;279:22926–22933
  25. Azmanov DN, Rodgers H, Auray-Blais C, et al. Persistence of the common Hartnup disease D173N allele in populations of European origin. Ann Hum Genet. 2007;71:755–761
  26. Moalem S, Percy ME, Kruck TP, et al. Epidemic pathogenic selection: an explanation for hereditary hemochromatosis?. Med Hypotheses. 2002;59:325–329
  27. Schroeder SA, Gaughan DM, Swift M. Protection against bronchial asthma by CFTR delta F508 mutation: a heterozygote advantage in cystic fibrosis. Nat Med. 1995;1:703–705
  28. Shih VE, Bixby EM, Alpers DH, et al. Studies of intestinal transport defect in Hartnup disease. Gastroenterology. 1971;61:445–453
  29. Tarlow MJ, Seakins JW, Lloyd JK, et al. Absorption of amino acids and peptides in a child with a variant of Hartnup disease and coexistent coeliac disease. Arch Dis Child. 1972;47:798–803

 Conflicts of interest The authors disclose no conflicts.

 Funding Supported by Swiss NF grant 31-108021/1 (to F.V.), the EUGINDAT (The European FP6 Project) (to F.V.), a fellowship from the University Research Priority Program “Integrative Human Physiology” at the University of Zurich (to D.S.), a grant from the Institute of Molecular Biotechnology of the Austrian Academy of Sciences (to J.M.P.), a grant from the Austrian Ministry of Sciences (to J.M.P.), and the EU network grant EuGeneHeart (to J.M.P.).

PII: S0016-5085(08)01893-3

doi: 10.1053/j.gastro.2008.10.055

Gastroenterology
Volume 136, Issue 3 , Pages 872-882.e3 , March 2009

Article Tools

* Image Usage & Resolution